Advertisement
UK markets close in 9 minutes

  • FTSE 100

    8,069.23
    +28.85 (+0.36%)
     

  • FTSE 250

    19,592.41
    -126.96 (-0.64%)
     

  • AIM

    752.71
    -1.98 (-0.26%)
     

  • GBP/EUR

    1.1655
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2486
    +0.0023 (+0.19%)
     

  • Bitcoin GBP

    50,866.30
    -1,101.44 (-2.12%)
     

  • CMC Crypto 200

    1,372.63
    -9.94 (-0.72%)
     

  • S&P 500

    5,005.36
    -66.27 (-1.31%)
     

  • DOW

    37,840.24
    -620.68 (-1.61%)
     

  • CRUDE OIL

    82.27
    -0.54 (-0.65%)
     

  • GOLD FUTURES

    2,347.80
    +9.40 (+0.40%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,900.60
    -188.10 (-1.04%)
     

  • CAC 40

    8,015.20
    -76.66 (-0.95%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

How Wall Street Reacted to Berkshire Hathaway Investment in Teva

Sarah Collins
Updated
How Wall Street Reacted to Berkshire Hathaway Investment in Teva

After Berkshire Hathaway (BRK) disclosed its investment of $358 million in Teva Pharmaceuticals (TEVA) on February 14, 2018, in a regulatory filing at the end of 4Q17, Wall Street analysts have had a lot to say about the investment. Teva Pharmaceuticals stock rose ~10.5% during the morning of February 15, 2018, before closing at a rise of ~7.7% on the day. The PowerShares International Dividend Achievers Portfolio (PID) rose ~1.3% on February 15, 2018.

Continue reading